Clinical Professionals invitation to “Perspectives on the Future of STEM in the UK” Webinar Series

Date: Thursday, July 2nd Time: 12pm In conjunction with CPL’s Future of Work Institute and Cpl Specialist Talent, the Clinical Professionals Group  invites you to our UK based Webinar Series “Perspectives on the Future of STEM”. During these times the world of work is changing for every industry, and STEM (Science, Technology, Engineering & Mathematics.)  is no

Continue Reading

“The most important thing is transforming our minds, for a new way of thinking, a new outlook: should we strive to develop a new inner world?” – Procurement Industry Analytics Report

Our latest industry analytics report features analysis on the procurement sector within the life sciences industry. Clinical Professionals Group CEO, Yvette Cleland comments: “As control of spend becomes more prominent in biopharmaceutical management’s message to the investor community, attention has been focused heavily again to the finance portfolio and most prominently through sourcing and procurement.

Continue Reading

AstraZeneca set to start COVID-19 antibody trials

AstraZeneca will start clinical trials of two antibodies targeting SARS-CoV-2, the virus that causes COVID-19, within the next two months. The two candidates have emerged from a partnership with Vanderbilt University in the US – focusing on up to six coronavirus-targeting neutralising antibodies – which was signed in April. The antibodies have the potential to

Continue Reading

Eli Lily commences trial for COVID-19 antibody treatment

Eli Lilly has recently begun dosing patients in the world’s first trial for treatment designed to attack SARS-CoV-2, the virus that causes COVID-19. This investigational treatment, referred to as LY-CoV555, is the first produced as a result of the collaboration between Lilly and AbCellera to create antibody therapies for the prevention and treatment of COVID-19. Scientists developed

Continue Reading

New UK trial looks to reduce COVID-19 drug development to a few weeks

The new UK trial initiative aims to cut the design phase of clinical studies for potential COVID-19 drugs from around 18 months to a few weeks. The ACCORD-2 collaboration will examine the effectiveness of repurposed medicines, potential new drugs, and currently unlicensed therapies in treating COVID-19 patients. Drug compounds that demonstrate effectiveness and safety in the early clinical trials stage

Continue Reading

A Future of Work Institute Webinar Series “Leading Through Times of Change”

During times of change it can be challenging for organisations to focus on business strategy while maintaining employee engagement, productivity and wellness. Now more than ever, your leadership style, employer proposition and employee experience are important. As we all adapt to new ways of working implementing and adopting virtual interviews and onboarding are a challenge.

Continue Reading